-R M Weinshilboum Researcher Activity Profile

Research Author Detailed Information 

R M Weinshilboum Publication Rate By Year

R M Weinshilboum has published 6 paper(s) in 2006, 10 paper(s) in 2007, 1 paper(s) in 2008, for a total of 17 research publications in total.

R M Rm Weinshilboum Author Information

LAST NAME: weinshilboum

FIRST NAME: R M

INITIALS: rm

AFFILIATION:

Papers

R M Weinshilboum's Publication Record

1. Genetic diversity and function in the human cytosolic sulfotransferases. Year Published: 2007
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, MN 55985, USA.
2. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics. Year Published: 2006
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
3. Pharmacogenetics and pharmacogenomics: development, science, and translation. Year Published: 2006
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Medical School-Mayo Foundation, Rochester, Minnesota 55905; email: weinshilboum.richard@mayo.edu.
4. Pharmacogenomics: challenges and opportunities. Year Published: 2006
Vanderbilt University, Nashville, Tennessee, USA. dan.roden@vanderbilt.edu
5. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Year Published: 2006
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
6. Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase. Year Published: 2006
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. weinshilboum.richard@mayo.edu
7. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Year Published: 2007
Department of Oncology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN , 55905, USA, goetz.matthew@mayo.edu.
8. The pharmacogenetics research network: from SNP discovery to clinical drug response. Year Published: 2007
Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, USA. kathy.giacomini@ucsf.edu
9. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches. Year Published: 2007
Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55901, USA. olsonj@mayo.edu
10. Human SULT1A1 gene: copy number differences and functional implications. Year Published: 2007
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
11. Human hydroxysteroid sulfotransferase SULT2B1 pharmacogenomics: gene sequence variation and functional genomics. Year Published: 2007
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
12. Effect of Resveratrol on 17 -Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1. Year Published: 2007
Toxicology and Metabolism, Biosciences Division, SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025. lalitha.iyer@sri.com.
13. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Year Published: 2007
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
14. Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Year Published: 2007
Toxicology and Metabolism, Biosciences Division, SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA.
15. Pharmacogenetics and pharmacogenomics: development, science, and translation. Year Published: 2006
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Medical School-Mayo Foundation, Rochester, Minnesota 55905, USA. weinshilboum.richard@mayo.edu
16. Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Year Published: 2007
Toxicology and Metabolism, Biosciences Division, SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA.
17. Metabolomics: a global biochemical approach to drug response and disease. Year Published: 2008
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. kaddu001@mc.duke.edu